JnJ Faulty Hip Implants: 7 more patients found fit for compensation
Mumbai: Several patients who claim to be suffering due to faulty hip implants manufactured by Johnson and Johnson (JnJ) have been claiming compensation. According to a recent media report, the state panel is deliberating the matter and has come across 7 more cases legible to seek compensation.
It has been learnt that these seven patients are currently in the process of collecting documents before their files are referred to Delhi for further proceedings.
Early this month, Medical Dialogues had reported that based on the recommendations of the central expert committee and the state-level committee, the Central Drugs Standard Control Organisation (CDSCO) had directed JnJ to pay Rs 74,57,180 to the first patient from Mumbai who received faulty hip implants made by the company.
This was the first case where M/s Johnson & Johnson had been directed to pay compensation for its faulty ASR hip implants manufactured and imported by M/s DePuy International Limited (now Johnson & Johnson Pvt Ltd).
The matter originated in the year 2010, wherein a hip replacement device namely DePuy ASR was recalled over reports of metal poisoning and high failures due to the presence of toxic chromium, cobalt and a design flaw that filtered into the body, causing danger to lives. It was sold in India by DePuy International, a subsidiary of J&J.
The company J&J recalled the faulty metal-on-metal ASR hip implants in 2010 globally after studies red-flagged the high rate of revision surgeries. However, the damage was done as several patients were affected by the faulty implants already.
In February 2016, the Government formed a panel led by Dr Arun Kumar Agarwal, former dean of Maulana Azad Medical College to investigate the case as India has no specific legal provisions to pay compensation in such cases.
With the development of the matter, the government in 2017 constituted the central expert panel to investigate the complaints about ASR hip implant devices.
It was decided that state-level committees would screen cases fit for compensation. They would then forward these cases to the central committee in Delhi, which along with Central Drugs Standard Control Organisation (CDSCO), would take a call on the compensation amount. The compensation range has been fixed at Rs 30 lakh to Rs 1.2 crore depending on degree of disability, age and risk factors.
Apart from the five-member expert panel, the Union Health Ministry has asked states and union territories to constitute separate committees so that they can receive such complaints from affected patients.
The expert committee findings say that over 3,600 patients with the faulty implants remain untraceable and that at least four deaths have been reported from those who underwent surgeries using these devices.
Also Read: JnJ Faulty Hip Implants: Another Expert panel formed to determine compensation to patients
Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at email@example.com. Contact no. 011-43720751